Network origin in Benyamin Toker first degree
Entity | Entity type | Industry | |
---|---|---|---|
Amaros Medical, Inc.
Amaros Medical, Inc. Medical SpecialtiesHealth Technology Amaros Medical, Inc. provides health care services. The company is headquartered in Menlo Park, CA.
1
| Private Company | Medical Specialties | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Benyamin Toker via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
University of Wisconsin | College/University | Doctorate Degree | |
FlowMedica, Inc.
FlowMedica, Inc. Medical SpecialtiesHealth Technology FlowMedica, Inc. develops intravascular systems and medical devices. The company's products include Benephit CV, PVSolo, PVMini, and XT Infusion systems. It also develops novel, proprietary, and minimally invasive intravascular systems for implementing Targeted Renal Therapy. The company was founded in 2002 and is headquartered in Fremont, CA. | Medical Specialties | Chief Executive Officer | |
Molecular Devices LLC
Molecular Devices LLC Medical SpecialtiesHealth Technology Molecular Devices LLC engages in the provision of bioanalytical solutions for protein and cell biology in life science research, pharmaceutical, and bio-therapeutic development. Its product portfolio includes platforms for screening, genomic and cellular analysis, colony selection, and microplate detection. The company was founded by Harden M. McConnell in July, 1983 and is headquartered in San Jose, CA. | Medical Specialties | Corporate Officer/Principal | |
Biometric Imaging, Inc.
Biometric Imaging, Inc. Medical SpecialtiesHealth Technology Biometric Imaging, Inc. manufactures cellular analysis instruments. It offers services to clinics, hospitals, blood banks, and cancer management centers for disease management and therapy monitoring. The company was founded by Bala S. Manian in 1992 and is headquartered in Mountain View, CA. | Medical Specialties | Founder | |
Neurofluidics, Inc.
Neurofluidics, Inc. Medical DistributorsDistribution Services Neurofluidics, Inc. develops neurological therapies. It also develops targeted and logical treatment approaches for patients suffering from neurological disorders. The company was founded in 2008 and is headquartered in Menlo Park, CA. | Medical Distributors | Chief Executive Officer | |
Vascular Therapeutics, Inc.
Vascular Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Vascular Therapeutics, Inc. develops glycol therapeutics for cardiovascular diseases. The firm also discovers and develops therapeutic agents to prevent & treat life-threatening blood clotting disorders. It serves cardiovascular diseases such as acute myocardial infarction, stroke, pulmonary embolism and deep vein thrombosis. The company was founded in July, 1994 and is headquartered in Mountain View, CA. | Pharmaceuticals: Other | Founder | |
Ablative Solutions, Inc.
Ablative Solutions, Inc. Medical SpecialtiesHealth Technology Ablative Solutions, Inc. develops and markets endovascular catheters for the treatment of hypertension. It offers solutions for heart failure, kidney disease, metabolic syndrome, and sleep apnea. The company was founded by Tim A. Fischell and David R. Fischell in 2011 and is headquartered in San Jose, CA. | Medical Specialties | President | |
Imetrx, Inc. | Chief Executive Officer | ||
Amaros, Inc.
Amaros, Inc. Packaged SoftwareTechnology Services Amaros, Inc. develops artificial intelligence for clinical development and post-market monitoring of therapeutics. The CEO of the American company is Vartan E. Ghazarossian. | Packaged Software | Chief Executive Officer | |
Visant Medical, Inc.
Visant Medical, Inc. Medical/Nursing ServicesHealth Services Part of Amring Pharmaceuticals, Inc., Visant Medical, Inc. is a clinical-stage medical device company based in Menlo Park, CA. Symatese SAS, a French company based in Lyon, was instrumental in the development of Lacrifill, significantly enhancing the product's design and performance, by leveraging its expertise in tissue regeneration, reconstruction, and related delivery systems. The company received FDA 510 (k) clearance in 2022 for Lacrifill® cross-linked hyaluronic acid-based canalicular occlusive device, which is intended to block tear drainage by occlusion of the canalicular system. The device is indicated for use, for up to 6 months, in patients experiencing dry eye symptoms. The company specializes in injectable crosslinked HA gels for many markets, including aesthetic, rheumatology, and ophthalmology. Symatese designs the most advanced medical device solutions thanks to their technology portfolio in hyaluronic acid, collagen, thermoplastics, and silicone. The company was founded by Cary J. Reich and Vartan E. Ghazarossian. Vartan E. Ghazarossian has been the CEO since incorporation. Visant Medical was acquired by Amring Pharmaceuticals, Inc. on December 18, 2023. | Medical/Nursing Services | Chief Executive Officer |
Statistics
International
United States | 13 |
Sectoral
Health Technology | 8 |
Consumer Services | 2 |
Distribution Services | 2 |
Technology Services | 2 |
Health Services | 2 |
Operational
Chief Executive Officer | 8 |
President | 7 |
Founder | 3 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Most connected contacts
Insiders | |
---|---|
Vartan E. Ghazarossian | 13 |
- Stock Market
- Insiders
- Benyamin Toker
- Company connections